Target intelligence / Profile preview

Cerebral perfusion (CBF)

Target
CBF
Molecular classification
Other
01

Overview

Cerebral perfusion refers to the physiological process of blood delivery to the brain's capillary bed, which is essential for maintaining neuronal viability by supplying oxygen and glucose and removing metabolic byproducts (StatPearls, NBK534830). It is quantitatively defined by the Cerebral Blood Flow (CBF) and is driven by the Cerebral Perfusion Pressure (CPP), the gradient between mean arterial pressure and intracranial pressure. The brain maintains stable perfusion across a range of systemic pressures through a process known as cerebral autoregulation, which involves the constriction or dilation of cerebral arterioles. Impairment of this process is a central feature in the pathophysiology of ischemic stroke, traumatic brain injury, and various forms of dementia (NIH, NINDS). While cerebral perfusion is a physiological state rather than a specific molecular target like a receptor or enzyme, it is a critical clinical endpoint for hemodynamic and neuroprotective therapies. Drugs such as vasopressors, osmotic diuretics, and certain calcium channel blockers are frequently employed in clinical settings to optimize perfusion and prevent secondary neurological damage.

Other names
Cerebral blood flowBrain perfusionCerebral perfusion pressureCPP
02

Mechanism of action

Pharmacological agents modulate cerebral perfusion by altering systemic mean arterial pressure (MAP), reducing intracranial pressure (ICP), or directly influencing cerebral vascular resistance through adrenergic signaling or calcium channel blockade (StatPearls, NBK537271).

03

Biological functions

Oxygen deliveryNutrient deliveryMetabolic waste removalCerebral autoregulationHomeostasis
04

Disease associations

Ischemic strokeTraumatic brain injuryDementiaHypertensionCerebral ischemiaHydrocephalusSubarachnoid hemorrhage
05

Safety considerations

Cerebral edemaHyperperfusion syndromeIntracranial hypertensionSecondary brain injuryHemorrhagic transformation
06

Interacting drugs

Norepinephrine

5 more in the full profile.

07

Biomarkers

Cerebral blood flow (CBF) volumeCerebral perfusion pressure (CPP)Mean transit time (MTT)Oxygen extraction fraction (OEF)Flow velocity (Transcranial Doppler)

Beyond the preview

Go deeper on Cerebral perfusion (CBF).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cerebral perfusion (CBF).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call